Emma Louise Robinson
Dr Emma Louise Robinson was born in North London, England and grew up in the nearby county of Hertfordshire. After her A-levels, Emma won a place to study Molecular & Cellular Biochemistry at Oxford University, where she was awarded a Nuffield scholarship for Academic Excellence. After graduating from Oxford in 2010, Emma moved to the University of Cambridge where she won a Wellcome Trust PhD studentship in Cardiovascular & Metabolic Disease and started her PhD research under the supervision of Prof. LLewelyn Roderick at The Babraham Institute in Cambridge.
In 2014, LLewelyn and Emma moved to KU Leuven, Belgium to join as Professor in the Laboratory of Experimental Cardiology alongside Prof. Karin Sipido. In Leuven in 2015, Emma was awarded an International scholarship from the KU Leuven Faculty of Medicine in order to complete her PhD research and thesis and obtain her PhD from the University of Cambridge. Throughout her PhD years, Emma was heavily involved in a number of projects, including investigating the roles of non-coding RNAs, histone lysine methylation and DNA methylation in regulation of the transcriptome in cardiac ageing, hypertrophy and disease-associated remodelling.
In 2018, Emma joined the lab of Prof. Stephane Heymans as a post-doctoral scientist, funded by the prestigious CVON Early HFPEF grant from the Dutch Heart Foundation. In Maastricht, Emma’s research focus is on identifying novel biomarkers for early detection of heart failure with preserved ejection fraction (HFpEF) and investigating novel mechanisms in the pathophysiology of this condition, for which common-place clinical biomarkers and neurohumoral-targeting treatments for heart failure are frequently ineffective. In 2018, Emma was awarded a CVON RECONNECT Talent grant to support her research on epigenetic mechanisms underlying pathophysiology of HFpEF.